INFI Key Stats
|08/05/2014 08:30 EDT||Misc||Q2 2014 Infinity Pharmaceuticals, Inc. Earnings Conference Call|
|08/05/2014||Earnings||Q2 2014 Infinity Pharmaceuticals, Inc. Earnings Result|
|06/17/2014||Misc||Annual General Meeting for Infinity Pharmaceuticals Inc|
|05/06/2014 16:30 EDT||Misc||Infinity Pharmaceuticals Inc 1Q2014 Earning Conference Call|
|05/06/2014||Earnings||Infinity Pharmaceuticals Inc 1Q2014 Earning Result|
|02/25/2014 08:30 EDT||Misc||Q4 2013 Infinity Conference Call and Webcast|
|02/04/2014||Earnings||Q4 2013 Infinity Earnings Results|
|11/12/2013 08:00 MDT||Misc||Infinity Announces New Date and Time for Credit Suisse 2013 Healthcare Conference Presentation and Webcast|
|11/07/2013 16:30 EDT||Misc||Q3 2013 Infinity Pharmaceuticals, Inc. Earnings Conference Call|
|11/07/2013||Earnings||Q3 2013 Infinity Pharmaceuticals, Inc. Earnings Release|
INFI Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Infinity Pharmaceuticals is down 14.74% over the last year vs S&P 500 Total Return up 11.11%, AbbVie up 14.37%, and Pharmacyclics down 16.87%.
Income Statement View Statement
Balance Sheet View Statement
Y-Ratings for INFI
Portfolio Strategies Featuring INFI
Did Infinity Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Company Website: http://www.infi.com
- IR Website: http://phx.corporate-ir.net/phoenix.zhtml?c=121941&p=irol-irhome
- HQ Country: United States
- HQ State/Province: Massachusetts
- Incorporation Country: United States
- Incorporation State/Province: Delaware
- Est. Current Fiscal Quarter End: December 31, 2014
- Est. Current Fiscal Year End: December 31, 2014
- Last Fiscal Quarter End: June 30, 2014
- Last Fiscal Year End: December 31, 2013
- NAICS: Pharmaceutical Preparation Manufacturing
- NAICS Code: 325412
- NAICS Industry: Pharmaceutical and Medicine Manufacturing
- NAICS Sector: Manufacturing
Infinity Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovering, developing & delivering medicines to people with difficult-to-treat diseases. Its primary product candidate is IPI-145, an oral inhibitor of phosphoinositide-3-kinase.
INFI Excel Add-In Codes
- Name: =YCI("INFI","name")
- Description: =YCI("INFI","description")
- Sector: =YCI("INFI","sector")
- Industry: =YCI("INFI","industry")
- Est. Current Fiscal Year End: =YCI("INFI","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.